Bill Nygren Harris Associates
Bill Nygren is a portfolio manager at Harris Associates and a long-time lead voice behind the Oakmark family of funds. He is known for a value philosophy that seeks growing businesses at discounts to intrinsic value rather than statistically cheap “cigar butts” alone. Nygren’s shareholder letters are popular for clear explanations of valuation, portfolio changes, and long-term equity ownership.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
APA Corp
APA
|
+$643M |
| 2 |
CHK
Chesapeake Energy Corporation
CHK
|
+$597M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$362M |
| 4 |
Melco Resorts & Entertainment
MLCO
|
+$283M |
| 5 |
GE Aerospace
GE
|
+$277M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oracle
ORCL
|
+$798M |
| 2 |
FedEx
FDX
|
+$512M |
| 3 |
General Dynamics
GD
|
+$352M |
| 4 |
TRW
TRW AUTOMOTIVE HOLDINGS CORP
TRW
|
+$318M |
| 5 |
Labcorp
LH
|
+$287M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 35.51% |
| 2 | Technology | 17.58% |
| 3 | Consumer Discretionary | 15.02% |
| 4 | Industrials | 8.03% |
| 5 | Healthcare | 6.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
HNI Corp
HNI
$3.55B
| $6.79M | 0.01% |
132,884
-462,747
| -78% | -$20.9M |
|
127
DNOW Inc
DNOW
$2.83B
| $6.05M | 0.01% |
235,136
+12,812
| +6% | +$350K |
|
|
128
General Dynamics
GD
$104B
| $5.4M | 0.01% |
39,250
-2,588,512
| -99% | -$352M |
|
129
Berkshire Hathaway Class B
BRK.B
$1.06T
| $4.04M | 0.01% |
26,919
-440
| -2% | -$63.5K |
|
130
Cenovus Energy
CVE
$60.7B
| $3.9M | 0.01% |
188,992
-4,307,225
| -96% | -$99.2M |
|
|
DISCK
131
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
| $3.74M | 0.01% |
110,929
-10,171
| -8% | -$347K |
|
132
Dick's Sporting Goods
DKS
$16.4B
| $3.07M | ﹤0.01% |
61,800
+525
| +0.9% | +$24.6K |
|
133
AbbVie
ABBV
$468B
| $2.78M | ﹤0.01% |
42,421
-36
| -0.1% | -$2.27K |
|
|
WBA
134
DELISTED
Walgreens Boots Alliance
WBA
| $2.31M | ﹤0.01% |
30,350
+8,550
| +39% | +$572K |
|
135
IBM
IBM
$222B
| $2.17M | ﹤0.01% |
14,126
+941
| +7% | +$150K |
|
136
3M
MMM
$92.3B
| $2.09M | ﹤0.01% |
15,183
-2,578
| -15% | -$331K |
|
137
Kohl's
KSS
$2B
| $2.08M | ﹤0.01% |
34,070
-4,796,320
| -99% | -$277M |
|
138
Coca-Cola
KO
$392B
| $2.06M | ﹤0.01% |
48,740
+400
| +0.8% | +$17.1K |
|
139
Johnson & Johnson
JNJ
$651B
| $1.99M | ﹤0.01% |
19,068
+370
| +2% | +$39K |
|
140
Abbott
ABT
$202B
| $1.96M | ﹤0.01% |
43,444
+1,000
| +2% | +$43.6K |
|
141
Capital Southwest
CSWC
$1.59B
| $1.74M | ﹤0.01% |
125,108
| – | – |
|
142
Starbucks
SBUX
$122B
| $1.65M | ﹤0.01% |
40,200
-1,000
| -2% | -$39.1K |
|
143
Thermo Fisher Scientific
TMO
$233B
| $1.47M | ﹤0.01% |
11,698
| – | – |
|
144
Pfizer
PFE
$160B
| $1.28M | ﹤0.01% |
43,443
| – | – |
|
|
HUB.B
145
DELISTED
HUBBELL INC CL-B
HUB.B
| $1.27M | ﹤0.01% |
11,920
| – | – |
|
146
Merck
MRK
$376B
| $1.15M | ﹤0.01% |
21,126
+711
| +3% | +$39.6K |
|
147
AGCO
AGCO
$7.48B
| $1.09M | ﹤0.01% |
+24,200
| New | +$1.07M |
|
148
Bristol-Myers Squibb
BMY
$137B
| $972K | ﹤0.01% |
16,467
+867
| +6% | +$48.9K |
|
|
DD
149
DELISTED
Du Pont De Nemours E I
DD
| $824K | ﹤0.01% |
11,741
+1,264
| +12% | +$84.5K |
|
150
ConocoPhillips
COP
$162B
| $801K | ﹤0.01% |
11,600
+100
| +0.9% | +$6.98K |
|
Similar funds
Bill Nygren's Q4 2014 Portfolio in Review
As of Q4 2014, Bill Nygren held 185 positions worth $64.4B, up 5.7% from $60.9B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Bill Nygren's Q4 2014 filing shows 10 new, 74 increased, 76 reduced and 3 closed positions. Its largest new stake was Chesapeake Energy Corporation: 143,802 shares worth $563M. The largest sale was Oracle, an estimated $798M.
By sector, the portfolio is most concentrated in Financials at 36% of assets, up from 35% a quarter earlier, followed by Technology and Consumer Discretionary.
- Bill Nygren's largest Q4 2014 buy was Chesapeake Energy Corporation: 143,802 shares worth $563M.
- Bill Nygren added most to APA Corp in Q4 2014, an estimated $643M increase.
- Bill Nygren's biggest Q4 2014 reduction was Oracle, cutting an estimated $798M.
- Bill Nygren fully exited Varian Medical Systems, Inc. in Q4 2014, selling an estimated $53.9M.
- Bill Nygren's ten largest holdings make up 34% of its $64.4B portfolio in Q4 2014.
- Bill Nygren opened 10 new positions and closed 3 in Q4 2014.
- Bill Nygren's portfolio value rose 5.7% quarter-over-quarter to $64.4B.
Based on Harris Associates's 13F filing for Q4 2014, filed 23 Jan 2015.